EMEA-001915-PIP01-15-M01

Key facts

Invented name
Waylivra
Active substance
Volanesorsen
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0404/2019
PIP number
EMEA-001915-PIP01-15-M01
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of familial chylomicronemia syndrome
Route(s) of administration
Intravenous use
Contact for public enquiries
Akcea Therapeutics

Tel. +1 6172070202
E-mail: info@akceatx.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating